Diagnosis is typically established by supervised fasting up to 72 h with concurrent measurements of beta-cell polypeptides (insulin, C-peptide, and proinsulin), detecting up to 99% of insulinomas [7,8]. This evidence concerns the gene INS and pancreatic insulinoma.